Tina Vilsbøll

Publikation

Publikationer pr. år 1994 2016 2017 2018 2019 2019

• 184 Tidsskriftartikel
• 20 Review
• 15 Konferenceabstrakt i tidsskrift
• 4 Letter
• 10 Mere
  • 3 Kommentar/debat
  • 3 Konferenceartikel
  • 2 Bidrag til bog/antologi
  • 1 Bog
  • 1 Poster

Publikationer pr. år

Publikationer pr. år

Søgeresultater

• 2018

  Individual and combined glucose-lowering effects of glucagon receptor antagonism and dipeptidyl peptidase-4 inhibition

  Maagensen, H., Haedersdal, S., Lund, A., Nielsen-Hannerup, E., Holst, J., Knop, F. & Vilsboll, T., 2018, I: Diabetologia. 61, s. S246-S247

  Publikation: Bidrag til tidsskrift › Konferenceabstrakt i tidsskrift › Forskning

• Individual and combined glucose-lowering effects of glucagon receptor antagonism and sodium-glucose cotransporter 2 inhibition

  Haedersdal, S., Lund, A., Maagensen, H., Nielsen-Hannerup, E., Holst, J., Knop, F. & Vilsboll, T., 2018, s. S312-S312.

  Publikation: Konferencebidrag › Poster › Forskning

• Is glucagon‐like peptide‐1 fully protected by the dipeptidyl peptidase 4 inhibitor sitagliptin when administered to patients with type 2 diabetes?

  Andersen, E. S., Lund, A., Bagger, J. I., Andreasen, C., Grøndahl, MF., Deacon, C. F., Hartmann, B., Holst, J. J., Knop, F. K. & Lauritsen, T. V., aug. 2018, I: Diabetes, Obesity and Metabolism. 20, 8, s. 1937-1943

  Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › peer review

  • Sitagliptin Phosphate 100%
  • Dipeptidyl-Peptidase IV Inhibitors 92%
  • Glucagon-Like Peptide 1 68%
  • Type 2 Diabetes Mellitus 52%
  • Dipeptidyl Peptidase 4 47%
  2 Citationer (Scopus)

• Metformin er en mulig glukagonlignende peptid-1-stimulator

  Bahne, E., Brønden, A., Vilsbøll, T. & Knop, F. K., 2018, I: Ugeskrift for Laeger. 180, 12, 4 s., V07170516.

  Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › peer review

  • Glucagon-Like Peptide 1 100%
  • Metformin 91%
  • Incretins 18%
  • Glucose 17%
  • Intestines 12%
  1 Citationer (Scopus)

• Metformin-induced glucagon-like peptide-1 secretion contributes to the actions of metformin in type 2 diabetes

  Bahne, E., Sun, E. W. L., Young, R. L., Hansen, M., Sonne, D. P., Hansen, J. S., Rohde, U., Liou, A. P., Jackson, M. L., de Fontgalland, D., Rabbitt, P., Hollington, P., Sposato, L., Due, S., Wattchow, D. A., Rehfeld, J. F., Holst, J. J., Keating, D. J., Vilsbøll, T. & Knop, F. K., 6 dec. 2018, I: JCI Insight. 3, 23, s. 1-16 e93936.

  Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › peer review

  • Glucagon-Like Peptide 1 100%
  • Metformin 91%
  • Type 2 Diabetes Mellitus 64%
  • Glucose 20%
  • Organized Financing 15%
  32 Citationer (Scopus)

• Model-Based Prediction of Plasma Concentration and Enterohepatic Circulation of Total Bile Acids in Humans

  Guiastrennec, B., Sonne, D. P., Bergstrand, M., Vilsboll, T., Knop, F. K. & Karlsson, M. O., sep. 2018, I: C P T: Pharmacometrics & Systems Pharmacology. 7, 9, s. 603-612

  Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › peer review

  • Enterohepatic Circulation 100%
  • Plasma 75%
  • Bile Acids and Salts 72%
  • Plasmas 63%
  • Acids 62%
  7 Citationer (Scopus)

  44 Downloads (Pure)

• Mono- and co-activation of the GIP and GLP-1 receptors inhibits bone resorption

  Bergmann, N. C., Lund, A., Heimburger, S. M., Gasbjerg, L. S., Jorgensen, N. R., Jessen, L., Hartmann, B., Holst, J. J., Christensen, M. B., Vilsboll, T. & Knop, F. K., 2018, I: Diabetologia. 61, S.1, s. S348-S348 717.

  Publikation: Bidrag til tidsskrift › Konferenceabstrakt i tidsskrift › Forskning

• Neuroprotective Mechanisms of Glucagon-like Peptide-1-based Therapies in Ischaemic Stroke: A Systematic Review based on Pre-Clinical Studies

  Marlet, I. R., Ölmestig, J. N. E., Vilsbøll, T., Rungby, J. & Kruuse, C., jun. 2018, I: Basic & Clinical Pharmacology & Toxicology. 122, 6, s. 559-569

  Publikation: Bidrag til tidsskrift › Review › peer review

  • Dipeptidyl Peptidase IV Inhibitor 100%
  • Neuroprotective 81%
  • Glucagon-Like Peptide 1 75%
  • Glucagon-Like Peptide-1 Receptor 72%
  • Agent Interacting With Transmitter, Hormone or Drug Receptor 71%
  20 Citationer (Scopus)

• No changes in levels of bone formation and resorption markers following a broad-spectrum antibiotic course

  Mikkelsen, K. H., Vilsboll, T., Holst, J. J., Hartmann, B., Knop, F. K. & Frost, M., 4 sep. 2018, I: BMC Endocrine Disorders. 18, 6 s., 60.

  Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › peer review

  1 Citationer (Scopus)

  46 Downloads (Pure)

• Postprandial effects of individual and combined GIP and GLP-1 receptor antagonism in healthy subjects

  Gasbjerg, L. S., Helsted, M. M., Sparre-Ulrich, A. H., Lanng, A. R., Stensen, S., Jakobsen, M. H., Hartmann, B., Christensen, M. B., Holst, J. J., Vilsboll, T., Rosenkilde, M. M. & Knop, F. K., 2018, I: Diabetologia. 61, S1, s. S246-S246 503.

  Publikation: Bidrag til tidsskrift › Konferenceabstrakt i tidsskrift › Forskning › peer review

• Presence of micro- and macroalbuminuria and the association with cardiac mechanics in patients with type 2 diabetes

  Jørgensen, P. G., Biering-Sørensen, T., Mogelvang, R., Fritz-Hansen, T., Vilsbøll, T., Rossing, P. & Jensen, J. S., 1 sep. 2018, I: European Heart Journal Cardiovascular Imaging. 19, 9, s. 1034-1041

  Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › peer review

  • Mechanics 100%
  • Albuminuria 75%
  • Type 2 Diabetes Mellitus 72%
  • Secondary Care Centers 25%
  • Coronary Disease 14%
  11 Citationer (Scopus)

• Protocol for Meal-time Administration of Exenatide for Glycaemic Control in Type 1 Diabetes Cases (The MAG1C trial): A randomised, double-blinded, placebo-controlled trial

  Johansen, N. J., Dejgaard, T. F., Lund, A., Vilsbøll, T., Andersen, H. U. & Knop, F. K., 2018, I: BMJ Open. 8, 6, 8 s., 021861.

  Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › peer review

  • Exenatide 100%
  • Meals 65%
  • Type 1 Diabetes Mellitus 65%
  • Placebos 50%
  • Insulin 35%
  2 Citationer (Scopus)

  53 Downloads (Pure)

• Recovery of gut microbiota of healthy adults following antibiotic exposure

  Palleja, A., Mikkelsen, K. H., Forslund, S. K., Kashani, A., Allin, K. H., Nielsen, T., Hansen, T. H., Liang, S., Feng, Q., Zhang, C., Pyl, P. T., Coelho, L. P., Yang, H., Wang, J., Typas, A., Nielsen, M. F., Nielsen, H. B., Bork, P., Wang, J., Vilsbøll, T., & 4 flereHansen, T., Knop, F. K., Arumugam, M. & Pedersen, O., 1 nov. 2018, I: Nature Microbiology. 3, 11, s. 1255-1265 11 s.

  Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › peer review

  • Gastrointestinal Microbiome 100%
  • Anti-Bacterial Agents 66%
  • Microbial Drug Resistance 40%
  • Genes 32%
  • Lactams 28%
  143 Citationer (Scopus)

• Semaglutide, reduction in glycated haemoglobin and the risk of diabetic retinopathy

  Vilsbøll, T., Bain, S. C., Leiter, L. A., Lingvay, I., Matthews, D., Simó, R., Helmark, I. C., Wijayasinghe, N. & Larsen, M., 1 apr. 2018, I: Diabetes, Obesity and Metabolism. 20, 4, s. 889-897 9 s.

  Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › peer review

  • semaglutide 100%
  • Diabetic Retinopathy 60%
  • Glycated Hemoglobin A 60%
  • Insulin 16%
  • Prior Authorization 12%
  90 Citationer (Scopus)

  48 Downloads (Pure)

• Semaglutide Treatment and Renal Function in the SUSTAIN 6 Trial

  Vilsbøll, T., Gumprecht, J., Silver, R. J., Hansen, T., Pettersson, J. & Wilding, J. P., 2018, I: Diabetes. 67, Supplement 1, s. 1084-P

  Publikation: Bidrag til tidsskrift › Konferenceabstrakt i tidsskrift › Forskning › peer review

• The bile acid-sequestering resin sevelamer eliminates the acute GLP-1 stimulatory effect of endogenously released bile acids in patients with type 2 diabetes

  Brønden, A., Albér, A., Rohde, U., Gasbjerg, L. S., Rehfeld, J. F., Holst, J. J., Vilsbøll, T. & Knop, F. K., 1 feb. 2018, I: Diabetes, Obesity and Metabolism. 20, 2, s. 362-369

  Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › peer review

  • Sevelamer 100%
  • Glucagon-Like Peptide 1 74%
  • Bile Acids and Salts 65%
  • Type 2 Diabetes Mellitus 47%
  • Cholecystokinin 31%
  17 Citationer (Scopus)

• The Effect of Ethanol on Inflammation Markers and FGF-21 in Healthy Individuals

  Lanng, A. R., Gasbjerg, L. S., Bergmann, N. C., Møller, H., Gillum, M., Gronbaek, H., Vilsbøll, T. & Knop, F. K., 2018, I: Diabetes. 67, Supplement 1, 2415-PUB.

  Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › peer review

  • fibroblast growth factor 21 100%
  • Ethanol 57%
  • Interleukin-10 48%
  • Inflammation 40%
  • albumin-bilirubin complex 12%

• The Role of Glucagon in the Pathophysiology and Treatment of Type 2 Diabetes

  Hædersdal, S., Lund, A., Knop, F. K. & Vilsbøll, T., feb. 2018, I: Mayo Clinic Proceedings. 93, 2, s. 217-239

  Publikation: Bidrag til tidsskrift › Review › peer review

  • Glucagon 100%
  • Type 2 Diabetes Mellitus 72%
  • Glucose 26%
  • Insulin 21%
  • Pancreatic Hormones 15%
  38 Citationer (Scopus)

  46 Downloads (Pure)

• The role of the incretins in the postprandial bone remodelling

  Helsted, M. M., Gasbjerg, L. S., Lanng, A. R., Stensen, S., Hartmann, B., Christensen, M. B., Holst, J. J., Vilsboll, T., Rosenkilde, M. M. & Knop, F. K., 2018, I: Diabetologia. 61, S1, s. S221-S221 449.

  Publikation: Bidrag til tidsskrift › Konferenceabstrakt i tidsskrift › Forskning › peer review

• Tværsektorielt samarbejde ved behandling af patienter med type 2-diabetes

  Munch, L., Røder, M. E., Rasmussen, I. H., Middelfart, H., Kaarsberg, N., Bennich, B., Knop, F. K. & Vilsbøll, T., 2018, I: Ugeskrift for Laeger. 180, 8, s. 690-693

  Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › peer review
• 2017

  A Fixed Ratio Combination of Insulin Degludec and Liraglutide (IDegLira) Reduces Glycemic Fluctuation and Brings More Patients with Type 2 Diabetes Within Blood Glucose Target Ranges

  King, A. B., Philis-Tsimikas, A., Kilpatrick, E. S., Langbakke, I. H., Begtrup, K. & Vilsbøll, T., apr. 2017, I: Diabetes Technology & Therapeutics. 19, 4, s. 255-264 10 s.

  Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › peer review

  • insulin degludec 100%
  • Liraglutide 84%
  • Blood Glucose 50%
  • Type 2 Diabetes Mellitus 45%
  • Glucose 16%
  17 Citationer (Scopus)

  47 Downloads (Pure)

• A sandwich ELISA for measurement of the primary glucagon-like peptide-1 metabolite

  Wewer Albrechtsen, N. J., Asmar, A., Jensen, F., Törang, S., Simonsen, L., Kuhre, R. E., Asmar, M., Veedfald, S., Plamboeck, A., Knop, F. K., Vilsbøll, T., Madsbad, S., Nauck, M. A., Deacon, C. F., Bülow, J., Holst, J. J. & Hartmann, B., 1 sep. 2017, I: American Journal of Physiology: Endocrinology and Metabolism. 313, 3, s. E284-E291

  Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › peer review

  • Glucagon-Like Peptide 1 100%
  • Enzyme-Linked Immunosorbent Assay 60%
  • Type 2 Diabetes Mellitus 12%
  • Dipeptidyl Peptidase 4 11%
  • Dipeptidyl-Peptidase IV Inhibitors 11%
  6 Citationer (Scopus)

• Bile acid sequestrants for glycemic control in patients with type 2 diabetes: A systematic review with meta-analysis of randomized controlled trials

  Hansen, M., Sonne, D. P., Mikkelsen, K. H., Gluud, L. L., Vilsbøll, T. & Knop, F. K., maj 2017, I: Journal of Diabetes and its Complications. 31, 5, s. 918-927 10 s.

  Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › peer review

  • Bile Acids and Salts 100%
  • Type 2 Diabetes Mellitus 72%
  • Meta-Analysis 71%
  • Systematic Reviews 70%
  • Randomized Controlled Trials 64%
  29 Citationer (Scopus)

• Cardiovascular safety and benefits of GLP-1 receptor agonists

  Dalsgaard, N. B., Brønden, A., Lauritsen, T. V. & Knop, F. K., 4 mar. 2017, I: Expert Opinion on Drug Safety. 16, 3, s. 351-363 13 s.

  Publikation: Bidrag til tidsskrift › Review › peer review

  • Glucagon-Like Peptide-1 Receptor 100%
  • Type 2 Diabetes Mellitus 58%
  • Safety 45%
  • semaglutide 38%
  • Liraglutide 31%
  18 Citationer (Scopus)

• Circulating Glucagon 1-61 Regulates Blood Glucose by Increasing Insulin Secretion and Hepatic Glucose Production

  Albrechtsen, N. J. W., Kuhre, R. E., Hornburg, D., Jensen, C. Z., Hornum, M., Dirksen, C., Svane, M., Gasbjerg, L. S., Jorgensen, N. B., Gabe, M. N., Balk-Moller, E., Albrechtsen, R., Winther-Sorensen, M., Galsgaard, K. D., Meissner, F., Jorsal, T., Lund, A., Vilsboll, T., Eliasen, R., Bojsen-Moller, K. N., & 9 flereIdorn, T., Deacon, C. F., Knop, F. K., Rosenkilde, M. M., Hartmann, B., Feldt-Rasmussen, B., Mann, M., Madsbad, S. & Holst, J. J., 7 nov. 2017, I: Cell Reports. 21, 6, s. 1452-1460

  Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › peer review

  • Proglucagon 100%
  • Glucagon 85%
  • Insulin Derivative 64%
  • Insulin Secretion 62%
  • Blood Glucose 52%
  13 Citationer (Scopus)

  119 Downloads (Pure)

• Current Therapies That Modify Glucagon Secretion: What Is the Therapeutic Effect of Such Modifications?

  Grøndahl, M. F., Keating, D. J., Vilsbøll, T. & Knop, F. K., 2017, I: Current Diabetes Reports. 17, 12, 10 s., 128.

  Publikation: Bidrag til tidsskrift › Review › peer review

  • Glucagon 100%
  • Therapeutic Uses 79%
  • Amylin Receptor Agonists 16%
  • Hypoglycemic Agents 16%
  • Sulfonylurea Compounds 16%
  8 Citationer (Scopus)

• Effect of exercise combined with glucagon-like peptide-1 receptor agonist treatment on cardiac function: A randomized double-blind placebo-controlled clinical trial

  Jørgensen, P. G., Jensen, M. T., Mensberg, P., Storgaard, H., Nyby, S., Jensen, J. S., Knop, F. K. & Lauritsen, T. V., jul. 2017, I: Diabetes, Obesity and Metabolism. 19, 7, s. 1040-1044

  Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › peer review

  • Liraglutide 100%
  • Glucagon-Like Peptide-1 Receptor 92%
  • Controlled Clinical Trials 77%
  • Placebos 49%
  • Exercise 46%
  17 Citationer (Scopus)

• Effect of Liraglutide Treatment on Prediabetes and Overweight or Obesity in Clozapine- or Olanzapine-Treated Patients With Schizophrenia Spectrum Disorder: A Randomized Clinical Trial

  Larsen, J. R., Vedtofte, L., Jakobsen, M. S. L., Jespersen, H. R., Jakobsen, M. I., Svensson, C. K., Koyuncu, K., Schjerning, O., Oturai, P. S., Kjaer, A., Nielsen, J., Holst, J. J., Ekstrøm, C. T., Correll, C. U., Vilsbøll, T. & Fink-Jensen, A., 1 jul. 2017, I: J A M A Psychiatry. 74, 7, s. 719-728 10 s.

  Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › peer review

  • Liraglutide 100%
  • Prediabetic State 91%
  • Olanzapine 86%
  • Clozapine 83%
  • Overweight 63%
  63 Citationer (Scopus)

• Efficacy and safety of fixed-ratio combination of insulin degludec and liraglutide (IDegLira) for the treatment of type 2 diabetes

  Vedtofte, L., Knop, F. K. & Vilsbøll, T., 4 mar. 2017, I: Expert Opinion on Drug Safety. 16, 3, s. 387-396 10 s.

  Publikation: Bidrag til tidsskrift › Review › peer review

  • insulin degludec 100%
  • Liraglutide 84%
  • Type 2 Diabetes Mellitus 45%
  • Safety 35%
  • IDegLira 25%
  11 Citationer (Scopus)

• Evidence connecting old, new and neglected glucose-lowering drugs to bile acid-induced GLP-1 secretion: a review

  Kårhus, M. L., Brønden, A., Sonne, D. P., Lauritsen, T. V. & Knop, F. K., sep. 2017, I: Diabetes, Obesity and Metabolism. 19, 9, s. 1214-1222

  Publikation: Bidrag til tidsskrift › Review › peer review

  • Glucagon-Like Peptide 1 100%
  • Bile Acids and Salts 88%
  • Glucose 53%
  • Pharmaceutical Preparations 35%
  • sodium-bile acid cotransporter 22%
  11 Citationer (Scopus)

• Exenatide: pharmacokinetics, clinical use, and future directions

  Knop, F. K., Bronden, A. & Lauritsen, T. V., 13 apr. 2017, I: Expert Opinion on Pharmacotherapy. 18, 6, s. 555-571 17 s.

  Publikation: Bidrag til tidsskrift › Review › peer review

  • Exenatide 100%
  • Pharmacokinetics 55%
  • Direction compound 53%
  • Glucagon-Like Peptide-1 Receptor 17%
  • Type 2 Diabetes Mellitus 15%
  31 Citationer (Scopus)

• Gastrisk aspirationsbehandling er et muligt alternativ til behandling af fedme

  Møller Christensen, M., Jorsal, T., Naver, L. P. S., Vilsbøll, T. & Knop, F. K., 2017, I: Ugeskrift for Laeger. 179, 32, 4 s., V03170198.

  Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › peer review

  • Weight Loss 100%
  • Stomach 87%
  • Obesity 84%
  • Gastrostomy 73%
  • Bariatric Surgery 67%

• Glucagon elimination is increased in patients with type 2 diabetes

  Lund, A. B., Grøndahl, M. F., Bagger, J. I., Holst, J. J., Christensen, M., Vilsboll, T. & Knop, F. K., 2017, I: Diabetologia. 60, s. S240-S240

  Publikation: Bidrag til tidsskrift › Konferenceabstrakt i tidsskrift › Forskning › peer review

  40 Citationer (Scopus)

• Glucagon-like peptide-1 receptor agonists and risk of acute pancreatitis in patients with type 2 diabetes

  Storgaard, H., Cold, F., Gluud, L. L., Lauritsen, T. V. & Knop, F. K., jun. 2017, I: Diabetes, Obesity and Metabolism. 19, 6, s. 906-908

  Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › peer review

  • Glucagon-Like Peptide-1 Receptor 100%
  • Pancreatitis 75%
  • Type 2 Diabetes Mellitus 58%
  • Placebos 53%
  • Randomized Controlled Trials 26%
  46 Citationer (Scopus)

• Impaired beta cell sensitivity to incretins in type 2 diabetes is insufficiently compensated by higher incretin response

  Tura, A., Bagger, J. I., Ferrannini, E., Holst, J. J., Knop, F. K., Vilsbøll, T. & Mari, A., dec. 2017, I: Nutrition, Metabolism and Cardiovascular Diseases. 27, 12, s. 1123-1129 7 s.

  Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › peer review

  • Incretins 100%
  • Type 2 Diabetes Mellitus 57%
  • Glucagon-Like Peptide 1 26%
  • Glucose 25%
  • Glucose Tolerance Test 18%
  8 Citationer (Scopus)

• Increased liver fat content in totally pancreatectomised patients

  Bagger, J. I., Lund, A. B., Albrechtsen, N. J. W., Christensen, M., Grøndahl, M. F., Hansen, C. P., Storkholm, J., Holst, J. J., Vilsboll, T. & Knop, F. K., 2017, I: Diabetologia. 60, S1, s. S572-S573

  Publikation: Bidrag til tidsskrift › Konferenceabstrakt i tidsskrift › Forskning › peer review

• Is double-blinding achievable in a placebo-controlled trial with the glucagon-like-peptide-1 receptor agonist liraglutide?

  Foghsgaard, S., Vedtofte, L., Bahne, E., Andreasen, C., Christiansen, L. K., Svare, J. A., Clausen, T. D., Mathiesen, E. R., Damm, P., Gluud, L. L., Knop, F. K. & Vilsboll, T., 2017, I: Diabetologia. 60, s. S369-S369

  Publikation: Bidrag til tidsskrift › Konferenceabstrakt i tidsskrift › Forskning

• Liraglutide for the Treatment of Antipsychotic Drug-Induced Weight Gain: Reply

  Fink-Jensen, A., Correll, C. U. & Vilsbøll, T., nov. 2017, I: J A M A Psychiatry. 74, 11, s. 1173-1174 2 s.

  Publikation: Bidrag til tidsskrift › Kommentar/debat › Forskning

  1 Citationer (Scopus)

• Mathematical Modelling of Glucose-Dependent Insulinotropic Polypeptide and Glucagon-like Peptide-1 following Ingestion of Glucose

  Røge, R. M., Bagger, J. I., Alskär, O., Kristensen, N. R., Klim, S., Holst, J. J., Ingwersen, S. H., Karlsson, M. O., Knop, F. K., Vilsbøll, T. & Kjellsson, M. C., okt. 2017, I: Basic & Clinical Pharmacology & Toxicology. 121, 4, s. 290-297 8 s.

  Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › peer review

  • Insulinotropic 100%
  • Glucagon-Like Peptide 1 94%
  • Polypeptide 49%
  • Eating 45%
  • Glucose 44%
  1 Citationer (Scopus)

• Metformin potentiates bile acid-induced GLP-1 secretion in patients with type 2 diabetes

  Bronden, A., Alber, A., Rohde, U., Rehfeld, J. F., Holst, J. J., Vilsboll, T. & Knop, F. K., 2017, I: Diabetologia. 60, s. S113-S113

  Publikation: Bidrag til tidsskrift › Konferenceabstrakt i tidsskrift › Forskning › peer review

• Near-normalization of glycaemic control with glucagon-like peptide-1 receptor agonist treatment combined with exercise in patients with type 2 diabetes

  Mensberg, P., Nyby, S., Jørgensen, P. G., Storgaard, H., Jensen, M. T., Sivertsen, J., Holst, J. J., Kiens, B., Richter, E., Knop, F. K. & Lauritsen, T. V., 1 feb. 2017, I: Diabetes, Obesity and Metabolism. 19, 2, s. 172-180 9 s.

  Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › peer review

  • Glucagon-Like Peptide-1 Receptor 100%
  • Liraglutide 58%
  • Type 2 Diabetes Mellitus 58%
  • Exercise 50%
  • Placebos 28%
  17 Citationer (Scopus)

  131 Downloads (Pure)

• Nonalcoholic Fatty Liver Disease Is Prevalent in Women With Prior Gestational Diabetes Mellitus and Independently Associated With Insulin Resistance and Waist Circumference

  Foghsgaard, S., Andreasen, C., Vedtofte, L., Andersen, E. S., Bahne, E., Strandberg, C., Buhl, T., Holst, J. J., Svare, J. A., Clausen, T. D., Mathiesen, E. R., Damm, P., Gluud, L. L., Knop, F. K. & Lauritsen, T. V., 1 jan. 2017, I: Diabetes Care. 40, 1, s. 109-116 8 s.

  Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › peer review

  • Gestational Diabetes 100%
  • Non-alcoholic Fatty Liver Disease 96%
  • Waist Circumference 89%
  • Insulin Resistance 73%
  • Fibrosis 19%
  24 Citationer (Scopus)

• Single-Dose Metformin Enhances Bile Acid-Induced Glucagon-Like Peptide-1 Secretion in Patients With Type 2 Diabetes

  Brønden, A., Albér, A., Rohde, U., Rehfeld, J. F., Holst, J. J., Vilsbøll, T. & Knop, F. K., nov. 2017, I: The Journal of clinical endocrinology and metabolism. 102, 11, s. 4153-4162 10 s.

  Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › peer review

  • Glucagon-Like Peptide 1 100%
  • Metformin 89%
  • Bile Acids and Salts 65%
  • Type 2 Diabetes Mellitus 47%
  • Cholecystokinin 27%
  14 Citationer (Scopus)

• Supportive and non-supportive interactions in families with a type 2 diabetes patient: an integrative review

  Bennich, B. B., Røder, M. E., Overgaard, D., Egerod, I., Munch, L., Knop, F. K., Vilsbøll, T. & Konradsen, H., 21 jul. 2017, I: Diabetology & Metabolic Syndrome. 9, 10 s., 57.

  Publikation: Bidrag til tidsskrift › Review › peer review

  • Type 2 Diabetes Mellitus 100%
  • Self-Management 30%
  • Communication 14%
  • Psychological Distress 9%
  • Blood Glucose 7%
  27 Citationer (Scopus)

  90 Downloads (Pure)

• The effect of empagliflozin on oxidative nucleic acid modifications in patients with type 2 diabetes: Protocol for a randomised, double-blinded, placebo-controlled trial

  Larsen, E. L., Cejvanovic, V., Kjær, L. K., Vilsbøll, T., Knop, F. K., Rungby, J. & Poulsen, H. E., maj 2017, I: BMJ Open. 7, 5, 6 s., e014728.

  Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › peer review

  • empagliflozin 100%
  • Nucleic Acids 63%
  • Type 2 Diabetes Mellitus 48%
  • Placebos 44%
  • Transferrin 34%
  8 Citationer (Scopus)

  49 Downloads (Pure)

• The impact of EndoBarrier gastrointestinal liner in obese patients with normal glucose tolerance and in patients with type 2 diabetes

  Rohde, U., Federspiel, C. A., Vilmann, P., Langholz, E., Friis, S. U., Krakauer, M., Rehfeld, J. F., Holst, J. J., Lauritsen, T. V. & Knop, F. K., 1 feb. 2017, I: Diabetes, Obesity and Metabolism. 19, 2, s. 189-199 11 s.

  Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › peer review

  • Type 2 Diabetes Mellitus 100%
  • Glucose 83%
  • Gallbladder Emptying 52%
  • Weight Loss 41%
  • Eating 37%
  9 Citationer (Scopus)

• THERAPY Liraglutide: preventing or postponing T2DM diagnosis?

  Vilsboll, T. & Knop, F. K., 1 jun. 2017, I: Nature Reviews Endocrinology. 13, s. 320-322

  Publikation: Bidrag til tidsskrift › Kommentar/debat › Forskning › peer review

  1 Citationer (Scopus)

• Use of antibiotics in childhood and risk of Type 1 diabetes: a population-based case-control study

  Mikkelsen, K. H., Knop, F. K., Lauritsen, T. V., Frost, M., Hallas, J. & Pottegård, A., 1 feb. 2017, I: Diabetic Medicine. 34, 2, s. 272–277

  Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › peer review

  • Type 1 Diabetes Mellitus 100%
  • Case-Control Studies 90%
  • Anti-Bacterial Agents 73%
  • Population 43%
  • Odds Ratio 16%
  21 Citationer (Scopus)

• Use of insulin providers versus insulin sensitizers and risk of out-of-hospital cardiac arrest - a nationwide case-time-control study

  Mohr, G. H., Sondergaard, K. B., Pallisgaard, J. L., Weeke, P., Jensen, A. K. G., Rajan, S., Lippert, F. K., Torp-Pedersens, C., Vilsboell, T. & Gislason, G., 2017, I: European Heart Journal Supplements. 38, Supplement 1, s. 425-426 2 s.

  Publikation: Bidrag til tidsskrift › Konferenceabstrakt i tidsskrift › Forskning › peer review

  49 Citationer (Scopus)

• Women with prior gestational diabetes mellitus and prediabetes are characterised by a decreased incretin effect

  Foghsgaard, S., Vedtofte, L., Andreasen, C., Andersen, E. S., Bahne, E., Bagger, J. I., Svare, J. A., Holst, J. J., Clausen, T. D., Mathiesen, E. R., Damm, P., Knop, F. K. & Vilsbøll, T., 1 jul. 2017, I: Diabetologia. 60, 7, s. 1344-1353 10 s.

  Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › peer review

  • Incretins 100%
  • Prediabetic State 99%
  • Gestational Diabetes 86%
  • Glucose 38%
  • Glucose Tolerance Test 15%
  8 Citationer (Scopus)